ClinicalTrials.Veeva

Find clinical trials for Glioblastoma (GBM) in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Glioma
Brain Cancer
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Phoenix, AZ, USA:

GammaTile and Stupp in Newly Diagnosed GBM (GESTALT)

In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...

Enrolling
Glioblastoma
Device: Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Phase 4

GT Medical Technologies

Scottsdale, Arizona, United States and 10 other locations

The purpose of the this study is to see if the use of a PET scan with 18F-fluciclovine (PET or Fluciclovine PET) in addition to the normal radiation...

Enrolling
Newly Diagnosed Glioblastoma
Drug: Fluciclovine PET guided Radiotherapy

Phase 2

St. Joseph's Hospital and Medical Center, Phoenix

Phoenix, Arizona, United States

with or without epacadostat in the treatment of recurrent glioblastoma (GBM). The investigators hypothesize that this combination p...

Active, not recruiting
Glioblastoma
Glioma
Drug: Retifanlimab
Drug: Bevacizumab

Phase 2

The Washington University
The Washington University

Phoenix, Arizona, United States and 3 other locations

The purpose of this study is to evaluate patients with glioblastoma that is MGMT-methylated (the MGMT gene is altered by a chemical change)....

Active, not recruiting
Brain Neoplasms
Other: Nivolumab Placebo
Drug: Nivolumab

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Phoenix, Arizona, United States and 122 other locations

OKN-007 combined with temozolomide(TMZ) in patients with recurrent glioblastoma(GBM). All patients will have been previously treate...

Active, not recruiting
Brain Glioblastoma
Recurrent Malignant Glioma
Drug: Temozolomide (TMZ)
Drug: OKN-007

Phase 2

Oblato

Phoenix, Arizona, United States and 12 other locations

This trial is an open-label, multicenter, Phase 0/2 trial that will enroll up to 50 participants with recurrent glioblastoma which are sched...

Enrolling
Glioblastoma
GBM
Drug: Abemaciclib
Drug: LY3214996

Early Phase 1

Nader Sanai

Phoenix, Arizona, United States and 2 other locations

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting
Glioblastoma Multiforme
Device: Optune®
NovoCure
NovoCure

Phoenix, Arizona, United States and 132 other locations

This is an open-label, multi-center Phase 0 study with an expansion phase that will enroll up to 24 participants with newly-diagnosed glioblastoma...

Enrolling
Glioblastoma
Glioblastoma Multiforme
Radiation: Radiation therapy
Drug: Niraparib

Early Phase 1

Nader Sanai

Phoenix, Arizona, United States and 1 other location

progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of i...

Enrolling
Glioblastoma
Radiation: Radiochemotherapy
Procedure: Standard surgery

Phase 3

Universitätsmedizin Mannheim

Phoenix, Arizona, United States and 18 other locations

with progressive or recurrent GBM....

Active, not recruiting
Recurrent GBM
Combination Product: SONALA-001 (ALA) and MR-Guided Focused Ultrasound device (MRgFUS)

Phase 1, Phase 2

SonALASense

Phoenix, Arizona, United States and 5 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems